Carotid ultrasound usefully predictive in post-stroke care

Rapid stenting of the carotid artery can significantly reduce the risk of secondary stroke, and a new Taiwanese study shows that carotid ultrasound imaging can help predict likely functional outcomes following such stenting in ischemic stroke patients with carotid artery stenosis.

The study is running in the March edition of Medicine.

Researchers from Changhua Christian Hospital and other institutions in Taiwan reviewed the cases of 67 patients who received carotid stenting.

They recorded pre-stenting and post-stenting carotid duplex data, which is gleaned in ultrasound scans to show how well blood is flowing.

They then compared resistance index (RI) differences at various carotid system sites and used the modified Rankin Scale (mRS) to assess functional capability.

Analyzing the results, the team found that, following stenting, mRS scores improved (n = 44) or stayed the same (n = 23).

They also found that measurements of RI assessed by carotid ultrasound at four weeks post-stenting correlated with midterm functional outcomes.

The latter led them to conclude that the scanning may assist physicians in predicting the likely mRS score at 12 months following carotid artery stenting.

“In the present study, no patients exhibited deterioration in mRS score following stenting and over half of the patients (65.7 percent) had improved mRS score, with the remainder having stationary or stable scores,” the authors write in their discussion. “This provides an indication that, in this patient series, carotid artery stenting was associated with improved outcomes in a substantial proportion of patients.”

The study is available in full for free.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.